Apoptosis: A target for potentiation of UV-induced IL-1RA synthesis by IVIg

被引:5
作者
Craciun, Ligia I.
DiGiambattista, Mario
Laub, Ruth
Goldman, Michel
Dupont, Etienne
机构
[1] Free Univ Brussels, Hop Erasme, Dept Immunol Haematol & Transfus, B-1070 Brussels, Belgium
[2] Res & Dev DCF CAF, B-1120 Brussels, Belgium
关键词
IVIg; UV-light; apoptosis; monocyte/macrophages; IL-1Ra;
D O I
10.1016/j.imlet.2007.02.010
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
IL-1Ra prevents IL-1 induced inflammatory signalling, a mechanism potentially important for several pathological conditions characterized by inflammation. When administered as a drug in the recombinant form, it displays a protective effect towards them. We postulated that this action could also be achieved by pharmacological activation of endogenous IL-1Ra production. We previously showed that photochemotherapy and UV-light increased monocyte/macrophages IL-1Ra secretion. A similar effect has been shown for IVIg. The aim of this study was to define optimal in vitro conditions for induction of IL-1 Ra secretion. As both agents induce lymphocytes apoptosis, we focused our analysis on the influence of IVIg on UV-induced-IL-1Ra production on this mechanism. After overnight preincubation at 37 degrees C, UV-irradiated PBL mixed with two IVIg concentrations (1 and 25 mg/ml) were cocultured with autologous PBMC. Apoptosis was measured by annexin V/PI. IL-1Ra secretion was evaluated by RT-PCR and Luminex microbead array assay. A significant additive dose-dependent influence of IVIg (+85%; p = 0.0005) on UV-induced IL-1Ra secretion, involved both Fc-receptor activation at a low dose (I mg/ml) and a potent apoptotic action on PBL reinforcing the UV effect at high concentrations (25 mg/ml). We conclude that lymphocyte apoptosis represents an important pathway contributing to enhancement of UV-induced monocyte/macrophages IL-1Ra production by IVIg and that these findings should be considered when evaluating in vivo protocols for photochemotherapy and IVIg treatment, in hope of improving efficacy. (C) 2007 Elsevier B.V. All rights reserved.
引用
收藏
页码:36 / 41
页数:6
相关论文
共 40 条
[11]   SELECTIVE INDUCTION OF INTERLEUKIN-1 RECEPTOR ANTAGONIST AND INTERLEUKIN-8 IN HUMAN MONOCYTES BY NORMAL POLYSPECIFIC IGG (INTRAVENOUS IMMUNOGLOBULIN) [J].
DESOUZA, VR ;
CARRENO, MP ;
KAVERI, SV ;
LEDUR, A ;
SADEGHI, H ;
CAVAILLON, JM ;
KAZATCHKINE, MD ;
HAEFFNERCAVAILLON, N .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1995, 25 (05) :1267-1273
[12]  
Dinarello C A, 1998, Int Rev Immunol, V16, P457, DOI 10.3109/08830189809043005
[13]   Therapeutic strategies to reduce IL-1 activity in treating local and systemic inflammation [J].
Dinarello, CA .
CURRENT OPINION IN PHARMACOLOGY, 2004, 4 (04) :378-385
[14]  
DONALD Y, 1998, ARTHRITIS RHEUM, V41, P1538
[15]   TREATMENT OF CUTANEOUS T-CELL LYMPHOMA BY EXTRACORPOREAL PHOTOCHEMOTHERAPY - PRELIMINARY-RESULTS [J].
EDELSON, R ;
BERGER, C ;
GASPARRO, F ;
JEGASOTHY, B ;
HEALD, P ;
WINTROUB, B ;
VONDERHEID, E ;
KNOBLER, R ;
WOLFF, K ;
PLEWIG, G ;
MCKIERNAN, G ;
CHRISTIANSEN, I ;
OSTER, M ;
HONIGSMANN, H ;
WILFORD, H ;
KOKOSCHKA, E ;
REHLE, T ;
PEREZ, M ;
STINGL, G ;
LAROCHE, L .
NEW ENGLAND JOURNAL OF MEDICINE, 1987, 316 (06) :297-303
[16]   Phagocyte receptors for apoptotic cells: recognition, uptake, and consequences [J].
Fadok, VA ;
Bratton, DL ;
Henson, PM .
JOURNAL OF CLINICAL INVESTIGATION, 2001, 108 (07) :957-962
[17]   Desensitization and subsequent transplantation kidney transplantation of patient using intravenous immunoglobulins (IVIg) [J].
Glotz, D ;
Antoine, C ;
Julia, P ;
Suberbielle-Boissel, C ;
Boudjeltia, S ;
Fraoui, R ;
Hacen, C ;
Duboust, A ;
Bariety, J .
AMERICAN JOURNAL OF TRANSPLANTATION, 2002, 2 (08) :758-760
[18]   Successful use of extracorporeal photochemotherapy in the treatment of severe acute and chronic graft-versus-host disease [J].
Greinix, HT ;
Volc-Platzer, B ;
Rabitsch, W ;
Gmeinhart, B ;
Guevara-Pineda, C ;
Kalhs, P ;
Krutmann, J ;
Hönigsmann, H ;
Ciovica, M ;
Knobler, RM .
BLOOD, 1998, 92 (09) :3098-3104
[19]  
Gullestad L, 2001, CIRCULATION, V103, P220
[20]   Interleukin-1-receptor antagonist in the Muckle-Wells syndrome [J].
Hawkins, PN ;
Lachmann, HJ ;
McDermott, MF .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (25) :2583-2584